This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: The University of Hong Kong. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: Innovations of Zhongjun Zhou in Anti-Aging Research
Introduction
Zhongjun Zhou is a notable inventor based in Hong Kong, CN. He has made significant contributions to the field of longevity and anti-aging research. His work focuses on the modulation of the SIRT1 protein, which plays a crucial role in cellular aging and metabolism.
Latest Patents
Zhongjun Zhou holds 1 patent related to his research. His patent, titled "Lamin A, an activator of longevity/anti-aging SIRT1 protein," provides methods for modulating the deacetylase activity of SIRT1 in cells. The invention outlines how modifying the binding affinity of lamin A to SIRT1 can influence its activity. Additionally, it includes methods for screening SIRT1-activating and inhibiting compounds based on the interaction between lamin A and SIRT1 proteins. The patent also discusses potential therapeutic uses of SIRT1-activating compounds for treating metabolic and aging-related diseases, as well as SIRT1-inhibiting compounds for addressing human malignancies.
Career Highlights
Zhongjun Zhou is affiliated with The University of Hong Kong, where he conducts his research. His work has garnered attention for its potential implications in the field of anti-aging therapies. He is recognized for his innovative approaches to understanding the mechanisms of aging at the cellular level.
Collaborations
Zhongjun Zhou collaborates with Baohua Liu, contributing to advancements in their shared research interests. Their partnership enhances the scope and impact of their work in the field of longevity.
Conclusion
Zhongjun Zhou's innovative research and patent contributions significantly advance the understanding of anti-aging mechanisms. His work holds promise for developing new therapeutic strategies to combat age-related diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
